PATRICK HARTNETT
Prescription History 1083174791
Psychiatry & Neurology - Epilepsy
in Hartford, CT
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for PATRICK HARTNETT, an active Epilepsy specialist practicing in Hartford, CT. Our medical registry currently tracks 30 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,092 documented patient claims. Among these therapy options, the most frequently utilized medication is Levetiracetam, which accounts for 179 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other CT PrescribersVs. CT Avg |
|---|---|---|---|
| Levetiracetam | 179 | $70.98 | ▲ More than typical |
About Levetiracetam: Levetiracetam is used to treat seizures (epilepsy). Show more ▾ It belongs to a class of drugs known as anticonvulsants. Levetiracetam may decrease the number of seizures you have. A pyrrolidinone and acetamide derivative that is used primarily for the treatment of SEIZURES and some movement disorders, and as a nootropic agent. In 2024, this provider wrote 179 Medicare prescriptions for Levetiracetam, about 3.3 times the volume of the typical Connecticut prescriber of this medication (54.8). Medicare paid an average of $70.98 per fill, versus $28.03 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 355.5 30-Day Fills standardized to 30-day supplies 10,569 Days of Medication total across all patients in 2024 | |||
| Lamotrigine | 89 | $32.92 | ▲ More than typical |
About Lamotrigine: Lamotrigine is used alone or with other medications to prevent and control seizures. Show more ▾ It may also be used to help prevent the extreme mood swings of bipolar disorder in adults. Lamotrigine is known as an anticonvulsant or antiepileptic drug. It is thought to work by restoring the balance of certain natural substances in the brain. This drug is not approved for use in children younger than 2 years due to an increased risk of side effects (such as infections). A phenyltriazine compound, sodium and calcium channel blocker that is used for the treatment of SEIZURES and BIPOLAR DISORDER. In 2024, this provider wrote 89 Medicare prescriptions for Lamotrigine, about 1.8 times the volume of the typical Connecticut prescriber of this medication (48.3). Medicare paid an average of $32.92 per fill, versus $14.98 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 219.5 30-Day Fills standardized to 30-day supplies 6,512 Days of Medication total across all patients in 2024 | |||
| Clonazepam | 62 | $10.39 | ≈ Typical |
About Clonazepam: Clonazepam is used to prevent and control seizures. Show more ▾ This medication is known as an anticonvulsant or antiepileptic drug. It is also used to treat panic attacks. Clonazepam works by calming your brain and nerves. It belongs to a class of drugs called benzodiazepines. An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses. In 2024, this provider wrote 62 Medicare prescriptions for Clonazepam, about 1.2 times the volume of the typical Connecticut prescriber of this medication (51.7). Medicare paid an average of $10.39 per fill, versus $9.70 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 86.3 30-Day Fills standardized to 30-day supplies 2,389 Days of Medication total across all patients in 2024 | |||
| Lacosamide | 59 | $214.74 | ▲ More than typical |
About Lacosamide: Lacosamide is used to prevent and control seizures. Show more ▾ It is an anticonvulsant or antiepileptic drug. It works by reducing the spread of seizure activity in the brain. An acetamide derivative that acts as a blocker of VOLTAGE-GATED SODIUM CHANNELS. It is used as an anticonvulsant, for adjunctive or monotherapy, in the treatment of PARTIAL SEIZURES. In 2024, this provider wrote 59 Medicare prescriptions for Lacosamide, about 1.6 times the volume of the typical Connecticut prescriber of this medication (37). Medicare paid an average of $214.74 per fill, versus $104.01 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 91 30-Day Fills standardized to 30-day supplies 2,722 Days of Medication total across all patients in 2024 | |||
| Topiramate | 57 | $21.72 | ▲ More than typical |
About Topiramate: Topiramate is used alone or with other medications to prevent and control seizures (epilepsy). Show more ▾ This medication is also used to prevent migraine headaches and decrease how often you get them. Topiramate will not treat a migraine headache once it occurs. If you get a migraine headache, treat it as directed by your doctor (such as by taking pain medication, lying down in a dark room). Topiramate is known as an anticonvulsant or antiepileptic drug. A sulfamate-substituted fructose analog that was originally identified as a hypoglycemic agent. It is used for the treatment of EPILEPSY and MIGRAINE DISORDERS, and may also promote weight loss. In 2024, this provider wrote 57 Medicare prescriptions for Topiramate, about 1.6 times the volume of the typical Connecticut prescriber of this medication (34.7). Medicare paid an average of $21.72 per fill, versus $13.50 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 115.5 30-Day Fills standardized to 30-day supplies 3,395 Days of Medication total across all patients in 2024 | |||
| Clobazam | 57 | $119.08 | ≈ Typical |
About Clobazam: This medication is used with other medications to help control seizures. Show more ▾ It belongs to a class of medications called benzodiazepines, which act on the brain and nerves (central nervous system) to produce a calming effect. This drug works by enhancing the effects of a certain natural chemical in the body (GABA). A benzodiazepine derivative that is a long-acting GABA-A RECEPTOR agonist. It is used as an antiepileptic in the treatment of SEIZURES, including seizures associated with LENNOX-GASTAUT SYNDROME. It is also used as an anxiolytic, for the short-term treatment of acute ANXIETY. In 2024, this provider wrote 57 Medicare prescriptions for Clobazam, about 1.2 times the volume of the typical Connecticut prescriber of this medication (47.3). Medicare paid an average of $119.08 per fill, versus $101.81 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 64.7 30-Day Fills standardized to 30-day supplies 1,894 Days of Medication total across all patients in 2024 | |||
| Oxcarbazepine | 43 | $96.98 | ≈ Typical |
About Oxcarbazepine: Oxcarbazepine is used alone or with other medications to treat seizure disorders (epilepsy). Show more ▾ A carbamazepine derivative that acts as a voltage-gated sodium channel blocker. It is used for the treatment of PARTIAL SEIZURES with or without secondary generalization. It is also an inducer of CYTOCHROME P-450 CYP3A4. In 2024, this provider wrote 43 Medicare prescriptions for Oxcarbazepine, about 1.2 times the volume of the typical Connecticut prescriber of this medication (35.4). Medicare paid an average of $96.98 per fill, versus $51.84 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 77.3 30-Day Fills standardized to 30-day supplies 2,286 Days of Medication total across all patients in 2024 | |||
| BriviactBrivaracetam | 42 | $3,390.52 | ≈ Typical |
About Briviact: Brivaracetam is used to treat seizures (epilepsy). Show more ▾ A pyrrolidinone compound that is used to treat partial onset seizures in adult patients. In 2024, this provider wrote 42 Medicare prescriptions for Briviact, about the same volume as the typical Connecticut prescriber of this medication (36.9). Medicare paid an average of $3,390.52 per fill, versus $1,706.51 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 48 30-Day Fills standardized to 30-day supplies 1,440 Days of Medication total across all patients in 2024 | |||
| Zonisamide | 40 | $37.10 | ▲ More than typical |
About Zonisamide: Zonisamide is used with other medications to prevent and control seizures (epilepsy). Show more ▾ Zonisamide is a sulfonamide anticonvulsant and a carbonic anhydrase inhibitor. It is unknown how zonisamide works to prevent seizures. A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization. In 2024, this provider wrote 40 Medicare prescriptions for Zonisamide, about 1.4 times the volume of the typical Connecticut prescriber of this medication (29). Medicare paid an average of $37.10 per fill, versus $32.66 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 78 30-Day Fills standardized to 30-day supplies 2,327 Days of Medication total across all patients in 2024 | |||
| Carbamazepine ErCarbamazepine | 36 | $218.36 | ▲ More than typical |
About Carbamazepine Er: Carbamazepine is used to prevent and control seizures. Show more ▾ This medication is known as an anticonvulsant or anti-epileptic drug. It is also used to relieve certain types of nerve pain (such as trigeminal neuralgia). This medication works by reducing the spread of seizure activity in the brain and restoring the normal balance of nerve activity. Some forms of this medication are also used to treat bipolar disorder. Carbamazepine can help to decrease extreme changes in mood and help you feel less agitated. A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties. In 2024, this provider wrote 36 Medicare prescriptions for Carbamazepine Er, about 1.4 times the volume of the typical Connecticut prescriber of this medication (25.2). Medicare paid an average of $218.36 per fill, versus $119.81 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 68 30-Day Fills standardized to 30-day supplies 2,011 Days of Medication total across all patients in 2024 | |||
| Divalproex Sodium | 32 | $177.00 | ▼ Less than typical |
About Divalproex Sodium: This medication is used to treat seizure disorders, certain psychiatric conditions (manic phase of bipolar disorder), and to prevent migraine headaches. Show more ▾ It works by restoring the balance of certain natural substances (neurotransmitters) in the brain. A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS. In 2024, this provider wrote 32 Medicare prescriptions for Divalproex Sodium, about 61% of the volume of the typical Connecticut prescriber of this medication (52.2). Medicare paid an average of $177.00 per fill, versus $45.77 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 57.2 30-Day Fills standardized to 30-day supplies 1,715 Days of Medication total across all patients in 2024 | |||
| Clorazepate Dipotassium | 30 | $64.99▼ below CT avg | ▲ More than typical |
About Clorazepate Dipotassium: Clorazepate is used to treat anxiety, acute alcohol withdrawal, and seizures. Show more ▾ This medication belongs to a class of drugs called benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. It works by enhancing the effects of a certain natural chemical in the body (GABA). A water-soluble benzodiazepine derivative effective in the treatment of anxiety. It has also muscle relaxant and anticonvulsant actions. In 2024, this provider wrote 30 Medicare prescriptions for Clorazepate Dipotassium, about 2.1 times the volume of the typical Connecticut prescriber of this medication (14.2). Medicare paid an average of $64.99 per fill, versus $66.64 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CT average for this medication. 51.7 30-Day Fills standardized to 30-day supplies 1,518 Days of Medication total across all patients in 2024 | |||
| FycompaPerampanel | 28 | $1,201.99▼ below CT avg | ▲ More than typical |
About Fycompa: Perampanel is used to treat certain types of seizures (including focal and generalized tonic-clonic seizures). Show more ▾ Perampanel belongs to a class of drugs known as anticonvulsants. In 2024, this provider wrote 28 Medicare prescriptions for Fycompa, about 1.3 times the volume of the typical Connecticut prescriber of this medication (22.2). Medicare paid an average of $1,201.99 per fill, versus $1,236.09 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CT average for this medication. 28 30-Day Fills standardized to 30-day supplies 814 Days of Medication total across all patients in 2024 | |||
| XcopriCenobamate | 26 | $2,039.29 | ▼ Less than typical |
About Xcopri: This medication is used to treat a certain type of seizure disorder (partial onset). Show more ▾ It is not known exactly how it works, but it may affect the action of some nerves that cause seizures. In 2024, this provider wrote 26 Medicare prescriptions for Xcopri, about half the volume of the typical Connecticut prescriber of this medication (46.6). Medicare paid an average of $2,039.29 per fill, versus $1,400.16 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 26 30-Day Fills standardized to 30-day supplies 780 Days of Medication total across all patients in 2024 | |||
| Gabapentin | 26 | $14.39▼ below CT avg | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2024, this provider wrote 26 Medicare prescriptions for Gabapentin, about a third of the volume of the typical Connecticut prescriber of this medication (75.3). Medicare paid an average of $14.39 per fill, versus $15.64 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CT average for this medication. 28.1 30-Day Fills standardized to 30-day supplies 788 Days of Medication total across all patients in 2024 | |||
| VimpatLacosamide | 26 | $2,631.78 | ▲ More than typical |
About Vimpat: Lacosamide is used to prevent and control seizures. Show more ▾ It is an anticonvulsant or antiepileptic drug. It works by reducing the spread of seizure activity in the brain. An acetamide derivative that acts as a blocker of VOLTAGE-GATED SODIUM CHANNELS. It is used as an anticonvulsant, for adjunctive or monotherapy, in the treatment of PARTIAL SEIZURES. In 2024, this provider wrote 26 Medicare prescriptions for Vimpat, about 1.3 times the volume of the typical Connecticut prescriber of this medication (20.2). Medicare paid an average of $2,631.78 per fill, versus $1,512.40 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 41.6 30-Day Fills standardized to 30-day supplies 1,247 Days of Medication total across all patients in 2024 | |||
| Pregabalin | 25 | $28.12▼ below CT avg | ▼ Less than typical |
About Pregabalin: This medication is used to treat pain caused by nerve damage due to diabetes, shingles (herpes zoster) infection, or spinal cord injury. Show more ▾ This medication is also used to treat pain in people with fibromyalgia. It is also used with other medications to treat certain types of seizures (focal seizures). A gamma-aminobutyric acid (GABA) derivative that functions as a CALCIUM CHANNEL BLOCKER and is used as an ANTICONVULSANT as well as an ANTI-ANXIETY AGENT. It is also used as an ANALGESIC in the treatment of NEUROPATHIC PAIN and FIBROMYALGIA. In 2024, this provider wrote 25 Medicare prescriptions for Pregabalin, about 68% of the volume of the typical Connecticut prescriber of this medication (36.8). Medicare paid an average of $28.12 per fill, versus $28.16 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CT average for this medication. 39 30-Day Fills standardized to 30-day supplies 1,169 Days of Medication total across all patients in 2024 | |||
| EpidiolexCannabidiol (Cbd) | 24 | $8,424.28 | ≈ Typical |
About Epidiolex: This medication is used to treat seizures due to certain medical conditions (such as Lennox-Gastaut syndrome, Dravet syndrome, tuberous sclerosis complex - TSC). Show more ▾ It is not known how this medication works for these seizures. Cannabidiol belongs to a class of drugs known as cannabinoids. Compound isolated from Cannabis sativa extract. In 2024, this provider wrote 24 Medicare prescriptions for Epidiolex, about 80% of the volume of the typical Connecticut prescriber of this medication (30.0). Medicare paid an average of $8,424.28 per fill, versus $4,268.58 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 24 30-Day Fills standardized to 30-day supplies 718 Days of Medication total across all patients in 2024 | |||
| Phenobarbital | 24 | $44.05 | ≈ Typical |
About Phenobarbital: This medication is used alone or with other medications to control seizures. Show more ▾ Controlling and reducing seizures lets you do more of your normal daily activities, reduces your risk of harm when you lose consciousness, and lessens your risk for a possibly life-threatening condition of frequent, repeated seizures. Phenobarbital belongs to a class of drugs known as barbiturate anticonvulsants/hypnotics. It works by controlling the abnormal electrical activity in the brain that occurs during a seizure. This medication is also used for a short time (usually no more than 2 weeks) to help calm you or help you sleep during periods of anxiety. It works by affecting certain parts of the brain to cause calming. A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. In 2024, this provider wrote 24 Medicare prescriptions for Phenobarbital, about the same volume as the typical Connecticut prescriber of this medication (26.3). Medicare paid an average of $44.05 per fill, versus $24.45 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 71.9 30-Day Fills standardized to 30-day supplies 2,156 Days of Medication total across all patients in 2024 | |||
| Sertraline Hcl | 23 | $5.41▼ below CT avg | ▼ Less than typical |
About Sertraline Hcl: This medication is used to treat certain mental/mood disorders (such as depression, panic attacks, obsessive compulsive disorder, post-traumatic stress disorder, social anxiety disorder). Show more ▾ It is also used to treat a severe form of premenstrual syndrome (premenstrual dysphoric disorder). Sertraline belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRIs). It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. A selective serotonin uptake inhibitor that is used in the treatment of depression. In 2024, this provider wrote 23 Medicare prescriptions for Sertraline Hcl, about a third of the volume of the typical Connecticut prescriber of this medication (63.6). Medicare paid an average of $5.41 per fill, versus $9.24 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CT average for this medication. 53.6 30-Day Fills standardized to 30-day supplies 1,593 Days of Medication total across all patients in 2024 | |||
| DilantinPhenytoin Sodium Extended | 23 | $225.91 | ≈ Typical |
About Dilantin: Phenytoin is used to prevent and control seizures (also called an anticonvulsant or antiepileptic drug). Show more ▾ It works by reducing the spread of seizure activity in the brain. An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. In 2024, this provider wrote 23 Medicare prescriptions for Dilantin, about the same volume as the typical Connecticut prescriber of this medication (23). Medicare paid an average of $225.91 per fill, versus $193.60 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 54.5 30-Day Fills standardized to 30-day supplies 1,622 Days of Medication total across all patients in 2024 | |||
| Lamotrigine ErLamotrigine | 23 | $647.98 | ≈ Typical |
About Lamotrigine Er: This product is used to prevent or control seizures (epilepsy). Show more ▾ This drug is not approved for use in children younger than 2 years due to an increased risk of side effects (such as infections). A phenyltriazine compound, sodium and calcium channel blocker that is used for the treatment of SEIZURES and BIPOLAR DISORDER. In 2024, this provider wrote 23 Medicare prescriptions for Lamotrigine Er, about 87% of the volume of the typical Connecticut prescriber of this medication (26.4). Medicare paid an average of $647.98 per fill, versus $267.55 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 57.1 30-Day Fills standardized to 30-day supplies 1,714 Days of Medication total across all patients in 2024 | |||
| Divalproex Sodium ErDivalproex Sodium | 20 | $42.65 | ▼ Less than typical |
About Divalproex Sodium Er: This medication is used to treat seizure disorders, mental/mood conditions (such as manic phase of bipolar disorder), and to prevent migraine headaches. Show more ▾ It works by restoring the balance of certain natural substances (neurotransmitters) in the brain. A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS. In 2024, this provider wrote 20 Medicare prescriptions for Divalproex Sodium Er, about half the volume of the typical Connecticut prescriber of this medication (40.4). Medicare paid an average of $42.65 per fill, versus $42.53 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 32 30-Day Fills standardized to 30-day supplies 938 Days of Medication total across all patients in 2024 | |||
| Rufinamide | 20 | $1,314.97 | ≈ Typical |
About Rufinamide: Rufinamide is used with other medications to prevent or control seizures (epilepsy) associated with Lennox-Gastaut syndrome (LGS). Show more ▾ This medication is an anticonvulsant. Rufinamide is thought to work by acting on the sodium channels in the brain that carry excessive electrical charges that may cause seizures. For treatment of Lennox-Gastaut syndrome. In 2024, this provider wrote 20 Medicare prescriptions for Rufinamide, about the same volume as the typical Connecticut prescriber of this medication (18.5). Medicare paid an average of $1,314.97 per fill, versus $1,204.98 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 20 30-Day Fills standardized to 30-day supplies 565 Days of Medication total across all patients in 2024 | |||
| AptiomEslicarbazepine Acetate | 16 | $2,560.87 | ▼ Less than typical |
About Aptiom: Eslicarbazepine is used alone or with other medications to treat a certain type of seizure disorder (focal seizures). Show more ▾ It belongs to a class of drugs known as anticonvulsants. Eslicarbazepine may reduce the number of seizures you have. In 2024, this provider wrote 16 Medicare prescriptions for Aptiom, about 67% of the volume of the typical Connecticut prescriber of this medication (24). Medicare paid an average of $2,560.87 per fill, versus $2,001.76 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22 30-Day Fills standardized to 30-day supplies 660 Days of Medication total across all patients in 2024 | |||
| Felbamate | 14 | $535.92 | ▼ Less than typical |
About Felbamate: Felbamate is used to treat severe seizures. Show more ▾ This medication should be used only when you cannot take other medications or when other medications have not been able to control your seizures. Felbamate is known as an anticonvulsant or anti-epileptic drug. A PEGylated phenylcarbamate derivative that acts as an antagonist of NMDA RECEPTORS. It is used as an anticonvulsant, primarily for the treatment of SEIZURES in severe refractory EPILEPSY. In 2024, this provider wrote 14 Medicare prescriptions for Felbamate, about 69% of the volume of the typical Connecticut prescriber of this medication (20.2). Medicare paid an average of $535.92 per fill, versus $331.24 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 30 30-Day Fills standardized to 30-day supplies 900 Days of Medication total across all patients in 2024 | |||
| Carbamazepine | 13 | $217.51 | ▼ Less than typical |
About Carbamazepine: Carbamazepine is used to prevent and control seizures. Show more ▾ This medication is known as an anticonvulsant or anti-epileptic drug. It is also used to relieve certain types of nerve pain (such as trigeminal neuralgia). This medication works by reducing the spread of seizure activity in the brain and restoring the normal balance of nerve activity. A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties. In 2024, this provider wrote 13 Medicare prescriptions for Carbamazepine, about half the volume of the typical Connecticut prescriber of this medication (25). Medicare paid an average of $217.51 per fill, versus $54.49 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 35 30-Day Fills standardized to 30-day supplies 1,050 Days of Medication total across all patients in 2024 | |||
| ValtocoDiazepam | 13 | $903.70 | ≈ Typical |
About Valtoco: This medication is used by people with epilepsy to treat a certain type of serious seizure that doesn't stop (seizure clusters). Show more ▾ Diazepam belongs to a class of drugs known as benzodiazepines. It may work by increasing the effect of a certain substance in your body (GABA), which helps calm the brain and nerves. A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. In 2024, this provider wrote 13 Medicare prescriptions for Valtoco, about the same volume as the typical Connecticut prescriber of this medication (13.2). Medicare paid an average of $903.70 per fill, versus $770.98 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 146 Days of Medication total across all patients in 2024 | |||
| KeppraLevetiracetam | 11 | $1,471.03▼ below CT avg | ▼ Less than typical |
About Keppra: Levetiracetam is used to treat seizures (epilepsy). Show more ▾ It belongs to a class of drugs known as anticonvulsants. Levetiracetam may decrease the number of seizures you have. A pyrrolidinone and acetamide derivative that is used primarily for the treatment of SEIZURES and some movement disorders, and as a nootropic agent. In 2024, this provider wrote 11 Medicare prescriptions for Keppra, about 63% of the volume of the typical Connecticut prescriber of this medication (17.4). Medicare paid an average of $1,471.03 per fill, versus $1,567.36 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CT average for this medication. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2024 | |||
| Lorazepam | 11 | $3.16▼ below CT avg | ▼ Less than typical |
About Lorazepam: This medication is used to treat anxiety. Show more ▾ Lorazepam belongs to a class of drugs known as benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. This drug works by enhancing the effects of a certain natural chemical in the body (GABA). A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent. In 2024, this provider wrote 11 Medicare prescriptions for Lorazepam, about a quarter of the volume of the typical Connecticut prescriber of this medication (48.1). Medicare paid an average of $3.16 per fill, versus $7.53 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CT average for this medication. 17 30-Day Fills standardized to 30-day supplies 359 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for PATRICK HARTNETT is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Epilepsy prescribing approach at this Hartford, CT practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among CT prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
